NCT01744093View on ClinicalTrials.gov

Doxycycline for COPD in HIV-Infected Patients

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

December 30, 2020

Conditions
HIVChronic Obstructive Pulmonary Disease (COPD)Emphysema
Interventions
DRUG

Doxycycline

100 mg twice daily (BID orally) x 24 weeks

DRUG

Placebo (sugar pill)

100 mg twice daily (BID orally) x 24 weeks

Trial Locations (1)

10021

Genetic Medicine, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT01744093 - Doxycycline for COPD in HIV-Infected Patients | Biotech Hunter | Biotech Hunter